Don’t let the cost of your diabetes or cardiovascular medication put your health at risk. We help eligible patients access brand-name Ozempic for $69.95 per month through the manufacturer’s Patient Assistance Program.
The Ozempic Prescription Assistance Program is a manufacturer-sponsored initiative run by Novo Nordisk (NovoCare) that provides brand-name Ozempic at no medication cost to qualifying patients who cannot afford it. The program is available to uninsured and underinsured U.S. residents who meet income
requirements, and it may also be available to Medicare Part D patients on a case-by-case basis. If approved, you receive your medication free of charge, and you can reapply as needed for continued access. However, the application process involves detailed eligibility verification, prescriber coordination, income
documentation, and periodic re-enrollment. For patients already managing the daily demands of diabetes, navigating this paperwork can feel like another full-time job. AffordMyPrescriptions removes that burden entirely. For a flat $69.95 per month, our Patient Advocates manage every step — from initial application through ongoing refills and annual re-enrollment — so you can focus on your health, not administrative complexity.
| Pharmacy(With Coupon) | PrIce (30-Day) | You Save W/ Us |
|---|---|---|
| Walgreens |
~$1,045 |
Save ~$975/mo |
| CVS Pharmacy |
~$1,059 |
Save ~$989/mo |
| Walmart |
~$1,048 |
Save ~$978/mo |
| Kroger |
~$1,011 |
Save ~$941/mo |
*Just a heads-up: retail prices are estimates based on public data and vary by pharmacy. Fortunately, Afford My Prescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
Ozempic may be one of the most important medications prescribed today for type 2 diabetes and cardiovascular protection — but it’s also one of the most expensive, with no generic alternative. Navigating the pharmaceutical assistance landscape for a medication this costly is complex: eligibility criteria change, documentation requirements can be confusing, and renewal deadlines carry real consequences if missed. At AffordMyPrescriptions, trained Patient Advocates manage the entire enrollment process on your behalf — from the first form to the last refill. Your cost is $69.95 per month, every month. No hidden fees, no annual savings caps, no prices that fluctuate. If we’re unable to secure your medication, you won’t be charged.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
The manufacturer offers a savings card for commercially insured patients that reduces costs to as low as $25 per fill (max savings $100/month). A self-pay program now offers ongoing pricing of $349–$499/month. GoodRx and SingleCare bring prices to $843–$1,059/month. Here’s why the PAP through AffordMyPrescriptions is the better long-term solution:
You may be eligible for the Ozempic Patient Assistance Program (NovoCare) if you meet the following general criteria:
Ozempic (semaglutide)
is a once-weekly injectable GLP-1 receptor agonist that lowers blood sugar, slows digestion to prevent spikes after meals, and reduces sugar production in the liver. It comes in four easy doses (0.25 mg starter, 0.5 mg, 1 mg, and 2 mg) in a simple prefilled pen. Ozempic is FDA-approved for adults with type 2 diabetes and to reduce cardiovascular risk — but it is not approved for weight loss.
How Ozempic Works: Mimicking Your Body’s Natural Sugar-Control Hormone
After you eat, your intestines release GLP-1, a hormone that tells your pancreas to release insulin, stops your liver from dumping extra sugar, and slows how fast food leaves your stomach. In type 2 diabetes, this natural system is too weak. Ozempic delivers a lab-made version of GLP-1 that lasts a full 7 days — so just one injection per week gives steady, around-the-clock control. It lowers blood sugar when it’s high, reduces appetite, supports modest weight loss, and protects your heart — all from a single weekly dose.
Generic or Biosimilar Availability: Why Ozempic Is Still Brand-Only
As of April 2026, there is no generic or biosimilar version of Ozempic available in the United States. Because Ozempic is a biologic medication made from living cells, it cannot have a simple generic — any lower-cost option must be an approved biosimilar that goes through years of extra testing. U.S. patents protect Ozempic until at least 2031–2032, with some patents lasting even longer. This means Ozempic remains a premium brand-name product, making the manufacturer’s Patient Assistance Program the most effective way for eligible patients to get it at no medication cost.
The list price is approximately $997 per month for a 28-day supply (all dose strengths). Retail prices range from $950 to over $1,300 depending on pharmacy and dose. With GoodRx coupons, prices range from ~$1,011 (Kroger) to ~$1,059 (CVS). SingleCare offers ~$844. The Novo Nordisk self-pay program now offers $349/month (0.25/0.5/1mg) or $499/month (2mg) ongoing. Through AffordMyPrescriptions, qualifying patients receive Ozempic at no medication cost — our $69.95 monthly fee covers advocacy and program management.
The $199/month introductory self-pay pricing from Novo Nordisk was a limited-time offer that ended March 31, 2026. The ongoing self-pay pricing through NovoCare is now $349/month for Ozempic 0.25mg, 0.5mg, or 1mg doses, and $499/month for the 2mg dose. This is still significantly lower than retail but represents $4,188–$5,988 per year — a heavy burden for a weekly lifelong medication. The PAP remains the most affordable pathway for those who qualify at $0 medication cost.
The NovoCare assistance program does evaluate Medicare patients on a case-by-case basis. Most Medicare Part D plans cover Ozempic when prescribed for type 2 diabetes, and the $2,100 annual out-of-pocket cap (2026) limits your total Part D drug spending. The manufacturer savings card ($25/fill) explicitly excludes all Medicare patients. Contact AffordMyPrescriptions and we’ll help you determine the most affordable pathway for your specific situation.
No. As a biologic medication, Ozempic will have biosimilars rather than traditional generics — and these are not expected at U.S. pharmacies until 2031 or later. While international markets may see earlier biosimilar availability (2026 in some countries), these products cannot legally be sold in the United States while U.S. patents remain in force. The Patient Assistance Program remains the most affordable access pathway.
Typically 2 to 4 weeks from completed application submission to first delivery. Our advocates work to expedite the process and can help you access bridge supplies or alternative savings programs if you need medication while your application is reviewed.
.
If you’re struggling with the high cost of Ozempic, our team can help you access assistance programs designed
to make your diabetes and cardiovascular treatment more affordable.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.